Xylem Inc. reported third quarter 2025 results with total revenue of $2.3 billion. Net income attributable to Xylem for the quarter was $227 million, or $0.93 per share. Net income margin declined 30 basis points to 10.0 percent. Adjusted net income was $333 million, or $1.37 per share. The third-quarter adjusted EBITDA margin was 23.2 percent, an increase of 200 basis points year-over-year. The company updated its full-year 2025 outlook, now forecasting revenue of approximately $9.0 billion, representing an increase of 5 to 6 percent on a reported basis and 4 to 5 percent on an organic basis. Full-year 2025 adjusted EBITDA margin is expected to be approximately 22.0 to 22.3 percent, an increase of 140 to 170 basis points from 2024. Full-year adjusted earnings per share are projected to be $5.03 to $5.08. The full-year free cash flow margin is expected to be approximately 9 to 10 percent.